<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04526301</url>
  </required_header>
  <id_info>
    <org_study_id>2020-02</org_study_id>
    <nct_id>NCT04526301</nct_id>
  </id_info>
  <brief_title>Home With TablO outcoMEs (HOME) Registry</brief_title>
  <acronym>HOME</acronym>
  <official_title>Home With TablO outcoMEs (HOME) Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Outset Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Outset Medical</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective, multicenter, single arm, post-market study to evaluate real world clinical&#xD;
      outcomes in ESRD patients receiving in-home dialysis on the Tablo Hemodialysis System.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 14, 2020</start_date>
  <completion_date type="Anticipated">January 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">January 31, 2023</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>Weekly Standardized Dialysis Adequacy</measure>
    <time_frame>12-months</time_frame>
    <description>Weekly standardized dialysis adequacy (stdKt/V) measured using the second-generation formula of Daugirdas. This formula normalizes urea clearance among heterogeneous hemodialysis schedules, where K=dialyzer clearance or urea, t=treatment time, and V=subject's volume of urea distribution. stdKt/V values of ≥ 2.1 are regarded as being adequate.</description>
  </primary_outcome>
  <other_outcome>
    <measure>Health Outcomes</measure>
    <time_frame>Change from Baseline at 12-months</time_frame>
    <description>Change in health outcomes from baseline to 12-months, as measured by the 12-item Short Form Health Survey (SF-12) Questionnaire. The questionnaire consists of 12 items weighted and summed to provide physical and mental health scores (PCS and MCS). The two composite scores are computed using the scores on twelve questions that range from 0 to 100. Higher scores mean a better outcome.</description>
  </other_outcome>
  <other_outcome>
    <measure>Sleep Outcomes</measure>
    <time_frame>Change from Baseline at 12-months</time_frame>
    <description>Change in sleep from baseline to 12-months, as measured by the Insomnia Severity Index (ISI). The minimum and maximum values are 0 and 28 scores, respectively. Higher scores mean a worse outcome.</description>
  </other_outcome>
  <other_outcome>
    <measure>Care Partner Burden</measure>
    <time_frame>Change from Baseline at 12-months</time_frame>
    <description>Change in care partner burden from baseline to 12-months, as measured by the Zarit Burden Interview-12 (ZBI-12) scale. The scale score is calculated by summing each item to produce a total score between 0 and 24, with higher scores indicating a worse outcome.</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">250</enrollment>
  <condition>End Stage Renal Disease</condition>
  <arm_group>
    <arm_group_label>Tablo Hemodialysis System</arm_group_label>
    <description>Home dialysis treatment with the Tablo Hemodialysis System</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Tablo Hemodialysis System</intervention_name>
    <description>Home hemodialysis treatments ~4 times a week.</description>
    <arm_group_label>Tablo Hemodialysis System</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with end stage renal disease (ESRD) who are on, or planning to be on, maintenance&#xD;
        hemodialysis.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Participant (patient and/or care partner) is at least 15 years of age and has provided&#xD;
             informed consent and has signed a Health Insurance Portability and Accountability Act&#xD;
             of 1996 (HIPAA) compliant authorization statement.&#xD;
&#xD;
          -  Participant weighs ≥ 34kg.&#xD;
&#xD;
          -  Participant has end stage renal disease (ESRD) adequately treated by maintenance&#xD;
             dialysis.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Participant and/or care partner is unable to read English or Spanish.&#xD;
&#xD;
          -  Participant has a home environment that is deemed inappropriate for home dialysis.&#xD;
&#xD;
          -  Participant and/or care partner is unable to successfully complete the Tablo training&#xD;
             program&#xD;
&#xD;
          -  Participant is pregnant or plans to become pregnant.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Josh Schumacher</last_name>
    <phone>(669) 231-8200</phone>
    <email>ClinicalTeam@outsetmedical.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Satellite Healthcare, Inc.</name>
      <address>
        <city>San Jose</city>
        <state>California</state>
        <zip>95128</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kshama Mehta</last_name>
    </contact>
    <investigator>
      <last_name>Wael Hussein, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Desert Cities Dialysis</name>
      <address>
        <city>Victorville</city>
        <state>California</state>
        <zip>92395</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Stolpp</last_name>
    </contact>
    <investigator>
      <last_name>Prashanth V Kumar, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Berkshire Medical Center</name>
      <address>
        <city>Pittsfield</city>
        <state>Massachusetts</state>
        <zip>01201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tammy Bator, RN</last_name>
    </contact>
    <investigator>
      <last_name>David Henner, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Peter's Health</name>
      <address>
        <city>Helena</city>
        <state>Montana</state>
        <zip>59601</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alice Luehr</last_name>
    </contact>
    <investigator>
      <last_name>Robert LaClair, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dialysis Center of Lincoln</name>
      <address>
        <city>Lincoln</city>
        <state>Nebraska</state>
        <zip>68512</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Corinne Morehead</last_name>
    </contact>
    <investigator>
      <last_name>Matt Glathar, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Queens Long Island Renal Institute</name>
      <address>
        <city>New Hyde Park</city>
        <state>New York</state>
        <zip>11040</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bonita Waites</last_name>
    </contact>
    <investigator>
      <last_name>Sayed Ali, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>NYU Grossman School of Medicine</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paula Dutka</last_name>
    </contact>
    <investigator>
      <last_name>Naveed Masani, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rogosin Institute</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10021</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kimberly Davis</last_name>
    </contact>
    <investigator>
      <last_name>Frank Liu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Virginia</name>
      <address>
        <city>Staunton</city>
        <state>Virginia</state>
        <zip>24401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Liz Kurland, BA, CCRC</last_name>
    </contact>
    <investigator>
      <last_name>Emaad M Abdel-Rahman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>August 14, 2020</study_first_submitted>
  <study_first_submitted_qc>August 24, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 25, 2020</study_first_posted>
  <last_update_submitted>September 7, 2021</last_update_submitted>
  <last_update_submitted_qc>September 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Tablo</keyword>
  <keyword>Outset Medical</keyword>
  <keyword>ESRD</keyword>
  <keyword>Home Hemodialysis</keyword>
  <keyword>HHD</keyword>
  <keyword>ESKD</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Failure, Chronic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

